chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patients received the Moderna Covid 19 vaccine after temperature excursion; Patients received the Moderna Covid 19 vaccine after temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patients received the Moderna Covid 19 vaccine after temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Patients received the Moderna Covid 19 vaccine after temperature excursion) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 13-May-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patients received the Moderna Covid 19 vaccine after temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients received the Moderna Covid 19 vaccine after temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patients received the Moderna Covid 19 vaccine after temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Patients received the Moderna Covid 19 vaccine after temperature excursion) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications was reported.  The vials were stored at frozen storage at the time of the excursion. The Lot number which were expired are 065K21Aand 045L21A. The vials reached a maximum temperature of 30 Fahrenheit Degrees and minimum of -18.9 Fahrenheit Degrees. The vaccines suffered 2 temperature excursions since April, both lasted less than 1 minute.  No treatment drug details was reported.
01/08/2021:Event occurred after 2nd vaccine.  Patient presents with headache and shortness of breath.  States that around noon today he had the gradual nonthunderclap onset of a bifrontal headache which is unusual for him and gradually worsening shortness of breath, . Taken to another facility and tested COVID positive  prior to transfer to hospital.  Not tested at hospital.  No cough, syncope, neck stiffness.  Patient denies: vomiting, Diarrhea, fever.  01/11/2022: remains in hospital
5 -10 mins after shot (lasting 5 mins or so)- right half of face felt weird. I just recall thinking it felt weird enough I had to touch my face to ensure it was okay.  10 mins after shot (lasting 30 mins - an hour) - electric shock type shooting pains in the right half of lips.  30 mins after shot (lasting 3 days) - pain in injection site  40 mins after shot (lasting 4 days) aching and feeling of unwellness all over.  An hour after (lasting 48 hours) - migraine (I do get migraines frequently, so this is not that strange) Just after the migraine started (lasting an hour) - electric shock type pains, minor, random location mostly lower body and back on the left side.  3 hours after the shot (lasting 3 days or so) - tired, very tired, and disoriented. Minor slurred speech, extra forgetful while completing tasks, dropping things and clumsiness; most of these have subsided or are not as often or as significant.  5 hours after - chills & low-grade fever (lasting a few hours)  8 hours after (lasting 8 hours or so) extreme dry mouth. It was as though I was producing zero saliva. Pain to open my mouth and the pain extended down the throat.   The morning after (still experiencing)- more than normal dry mouth but not extreme like above, accompanied by a strange taste that wasn't too bothersome, just annoying. Other foods and drink taste normal, it is as though my saliva tastes like blood. *I was drinking 17-10 16oz cups of water a day and still was not able to keep my mouth from feeling dry. I had trouble swallowing food without a sip of water. This now is not constant but comes and goes. Saliva production is still not back to normal, and I am still drinking an increased amount of water but trying to drink less.   4 days later (lasting 24 hours) swelling and what felt like sores on the top of my mouth.  As though the top of my mouth was peeling away. It was sensitive to touch but not an open wound that I could see.    Still experiencing - the taste is still present like a mix of blood and butter, and now more pronounced. The actual feeling in my mouth is different. Like my saliva is not normal. My lips are always dry, and my mouth is always dry, but I am well hydrated. It could feel this dry even while drinking water.
seizures lasting 10-12 minutes, hospitalized since May 16, 2021. Transferred to hospital on May 28, Expected to be transferred to long term care on June 14, 2021 .
Pharmacist administered flu shot into my shoulder. Pain started next day and increased. Received cortisone shot on Nov. 8. Still having pain and limited movement of arm/shoulder.
This spontaneous report as received from a registered nurse regarding a patient of unknown demographics. There was no information about concurrent condition, historical medication and concomitant medication. On 11-NOV-2016 the patient was vaccinated with expired dose of ZOSTAVAX lot # L029483, expiration date-06-NOV-2016, subcutaneous. No adverse event was reported. The outcome of the event was unknown. No PQC (product quality complaint) was involved. Additional information has been requested.
temp 102 30JUN92 poss febrile seizure reported by parent; 1JUL92 t98.8-alert, asymptomatic;
Information has been received from a medical assistant concerning a female patient who was vaccinated with a pneumococcal 23v polysaccharide vaccine (lot#651859/0877R).  Subsequently, the patient experienced swelling at the site of injection, numbing of the lips, and itching eyes.  No product quality compliant was involved.  No other  information was provided.  The patient recovered.  It was also reported that another patient had a similar reaction.  Additional information has been requested.
Swelling to lt. thigh on site of Vaccine, reported to have been there with mild tactile fever x3 days.
Patient received second dose of shingrix vaccine in her Right arm on 1/9/2021. Patient came in today 1/13/21 and stated that her arm was sore immediately after and now 5 days later, it is still feeling very sore. She also said it became red after the injection and it is still red and warm to the touch. She also stated that she only had a little soreness for a day with the first dose. She was educated on OTC products that can help with symptoms and advised to follow up with PCP if symptoms persist.
pt recvd vax 140PM 12JAN95 & @ 11AM 13JAN95 mom called & said that pt had been sleeping since given vax w/difficulty arousing; temp during the noc 102 & @ 8AM t102 & given APAP; inject site swollen, red, & warm;
Bursitis in right knee - moderate pain for first 12 hours. Joint was swollen and warm to touch. Pain and swelling has gradually subsided but it is still present 5 days later.  Injection site reaction - large bruising compared to previous COVID injections or any flu shots in the past.
Pain, warmth (entire upper arm warm to the touch)and swelling to the point of hardness, of entire left upper arm, between shoulder and elbow.
her fingers and one toe swelled / swelling is on both hands but more pronounced on the left; The toe turned purple; intense itching on her fingers; reduced range of motion in her neck like a stiff neck; sores present on both hands; had reduced range of motion in her neck; sore arm that lasted 2-3 days; not feeling well; like she had the flu; Extreme fatigue presented lasting a week; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 67-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 11th December 2020, the patient received the 1st dose of Shingrix (intramuscular). On 11th December 2020, less than a day after receiving Shingrix, the patient experienced pain in arm, feeling unwell, influenza-like symptoms and fatigue. On an unknown date, the patient experienced swelling of fingers, skin discoloration, pruritus, stiff neck, skin ulcer and mobility decreased. On an unknown date, the outcome of the pain in arm and pruritus were recovered/resolved and the outcome of the feeling unwell, fatigue and stiff neck were recovering/resolving and the outcome of the influenza-like symptoms, skin discoloration and mobility decreased were unknown and the outcome of the swelling of fingers and skin ulcer were not recovered/not resolved.   It was unknown if the reporter considered the pain in arm, feeling unwell, influenza-like symptoms, fatigue, swelling of fingers, skin discoloration, pruritus, stiff neck, skin ulcer and mobility decreased to be related to Shingrix.  Additional details were provided as follows: The case was reported by patient herself. The patient received Shingrix in the left arm. The patient reported a sore arm that lasted 2 to 3 days.  The evening of the vaccination date, started to not feel well like she had the flu. Extreme fatigue presented lasting a week.  A few days after vaccination, the patient's fingers and one toe swelled, the toe turned purple.  The swelling was on both hands but more pronounced on the left side.  There was intense itching on her fingers.  The patient had reduced range of motion in her neck like a stiff neck.  Her fingers were still swollen and there were now sores present on both hands due to the swelling. Less than a month after receiving Shingrix the patient experienced Skin discolouration, Pruritus, Musculoskeletal stiffness, Skin ulcer and Mobility decreased and several days after receiving Shingrix the patient experienced the patient experienced swelling of fingers. The reporter consented to follow up.
Began with diarrhea in the morning, progressed by early afternoon to have chills, fatigue.  Progressed by 7 pm to severe chills, fever of 100.9, severe muscular and joint aches, diarrhea.  Relieved minimally by three doses of 400 mg ibuprofen throughout day.  Called Dr on call to see if urgent care center visit was warranted.  Symptoms except extreme fatigue resolved by 11/13/2013 at 2 a.  Noticed right eye blurred vision by 11/13/2013 at 5 pm, with minimal aches, continued fatigue.
This case was reported by a physician via another manufacturer Merck and described the occurrence of allergic reaction in a subject of unspecified age and gender who was vaccinated with influenza virus vaccine (manufacturer unspecified). On an unspecified date the subject received unspecified dose of seasonal influenza vaccine (unknown). At an unspecified time after vaccination with seasonal influenza vaccine, the subject experienced allergic reaction, welt and swelling. The subject had an allergic reaction of welts and swelling after vaccination with an influenza vaccine. "This occurred years ago". No other information was provided. At the time of reporting the outcome of the allergic reaction, welt and swelling was unspecified.
21APR92 fever 104.2 rx tepid baths-APAP; 22APR92 fever 103-advil susp; 23APR92 diarrhea;
4/18/2005 Passed out at school - ongoing blackout events through June 9/12-24/05 Passed out with increase severity of convulsions. Time frame from 1 to 1.5 hours each time. 7 episodes within 13 days. Information from 60 day follow-up report states: 1/8/2006 My daughter has had episodes since she received her vaccines. She had several in April, again in June, several more in September and one again 5 weeks ago. We have been to Dr after Dr and still have not found out what is going on with her. This week she sees a Cardiologist. We have ruled out several things but still have no answer as to why these things are happening. In September the episodes were convulsive in nature. In December she passed out and was unconscious for 45 minutes and a few weeks after that she had symptoms of appendicitis. She has multiple nodules on her thyroid which we believe are benign. She has had more tests in the last year than I have had in my lifetime. And it all coincidentally began two days after her vaccination. So to answer your letter, NO she has not recovered from the adverse events that were reported.   Information received from discharge summary states neurosis.  Information from medical records states speech difficulty. msv
This prospective pregnancy case was reported by a consumer and described the occurrence of injection site tenderness in a 36-year-old female subject who was vaccinated with BOOSTRIX (GlaxoSmithKline). A physician or other health care professional has not verified this report during pregnancy. On 5 March 2014 the subject received a dose of BOOSTRIX (unknown). Her last menstrual period was in July 2013 and estimated delivery date was 01 May 2014. The pregnancy was by normal conception, she was not using contraception. No previous pregnancies. There was no evidence of a defect from prenatal testing, "three other tests"; details were not provided. On 5 March 2014, within hours of vaccination with BOOSTRIX, the subject experienced site tenderness/soreness and vaccine exposure during pregnancy. The subject was 33 weeks gestation, 3rd trimester at the time of vaccination. The subject reported a couple hours after vaccination she experienced tenderness and soreness at the injection site and went away after 24 hours. The tenderness and soreness at the injection reappeared on 12 March 2014. At the time of this report the tenderness and soreness continued, but was less severe than the previous time. At the time of the report injection site tenderness/soreness was improved. The pregnancy was ongoing. The case was closed and lost to follow up because the reporter wanted to remain anonymous and declined to provide information.
Very sleepy all day Saturday, March 13th. Overnight, had hallucinations and sleepwalking, was found at the foot of the bed, confused. Went back to sleep and when he awoke he was fine.
Patient reported soreness and redness on the left arm which spread from the armpit to the elbow. Developed severe nausea, dizziness and fatigue on 9.14.13 which persisted through 9.16.13.
I felt tired on 2/16/2023. On 2/17/2023, I felt more tired as the day went on. I took a nap for about an hour and a half during the middle of the day. For the rest of the day, I just felt really tired and fatigued. On 2/18/2023, I was lethargic and somewhat congested in the head. I had a sore throat. I had no energy and slept virtually the whole day. I took a home antigen test and got a positive result. About 3 PM that afternoon, I had a telehealth visit and got a prescription for Paxlovid, which I began taking that day. On 2/19/2023 and 2/20/2023, I felt fatigued, lethargic and congested. I improved on 2/21/2023 and 2/22/2023. I was less congested, though I was still lethargic. By 2/23/2023, though, I felt pretty much back to normal.
blood cells dieing; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of BLOOD DISORDER (blood cells dieing) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BLOOD DISORDER (blood cells dieing). At the time of the report, BLOOD DISORDER (blood cells dieing) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.   Treatment information was not provided
only liquid portion was administered; only liquid portion was administered; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a 11-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA689A, expiry date 31st October 2022) for prophylaxis.   On an unknown date, the patient received Menveo. On an unknown date, unknown after receiving Menveo, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.  Additional details were provided as follows: The reporter was a medical assistant. The age at vaccination was not reported. The reporter reported that only liquid portion of Menveo was administered to the patient, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The vaccine administration facility was the same as primary reporter. The reporter consented to follow up. The case had been linked to US2022039263, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022039263:Same reporter
Patient presented to the emergency department with symptoms consistent with R facial paralysis due to Bell?s Palsy. Symptoms began the morning after getting the first dose of the Moderna vaccine.
Shortness of breath, fatigued, Pain in neck and shoulders, low oxygen level, racing heartbeat and stabbing chest pain. Diagnosed with pleuropericarditis/myopericarditis
Had shingles three times after the shot/Suspected vaccination failure; Shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Had shingles three times after the shot/Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK receipt date: 18-MAR-2023 The case was received from the patient interactive digital media. The patient had the shingles six times, three before the shot, three times after the shot.  The reporter stated that shot would not prevent you from having them if you had already had them, but they usually are not as bad after the shot.  The patient stated still, no picnic. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available. This case is linked with US2023AMR052388, reported by same reporter.; Sender's Comments:  US-GSK-US2023AMR052388:Same reporter
eyes swollen shut & rash on body;played w/pet raccoon that died;not examined, but thought might have died from rabies;
04/08/2005-PC from father-stated that red raised rash started earyl this morning, no fever and eating ok. Felt warm but did not check temp, playing without problems. PC to father as follow up 04/18/05 states rash increased on 04/08/05 so taken to DR in evening, "ran tests" related that DR did not feel that rash was related to shots. Given Benadryl x2 days and rash gone.
Shingrix recalled vaccines were administered to several patients; Drug dispensing error; This non-serious case was reported by a other health professional via call center representative and described the occurrence of recalled drug administered in an unspecified number of patients who received Herpes zoster (Shingrix) (batch number YC5Y7) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced recalled drug administered (Verbatim: Shingrix recalled vaccines were administered to several patients) and drug dispensing error (Verbatim: Drug dispensing error). The outcome of the recalled drug administered and drug dispensing error were unknown.   Additional Information: GSK receipt date: 09-Aug-2023 Business director of several health clinics reported that the Shingrix recalled vaccines were administered to several patients.  No adverse events had been reported. The sever patient received recalled vaccine which led to recalled drug administered and drug dispensing error  The reporter was not asked for follow up.
Pt felt dizzy, lightheaded. Face was flushed and burning sensation. No other treatment.
Pain at injection site; received the first dose of Shingrix via subcutaneous route; This case was reported by a nurse via call center representative and described the occurrence of injection site pain in a 64-year-old male patient who received Herpes zoster (Shingrix) (batch number 22S3B, expiry date 25th March 2022) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix (subcutaneous). On an unknown date, unknown after receiving Shingrix, the patient experienced intramuscular formulation administered by other route. On an unknown date, the outcome of the intramuscular formulation administered by other route was unknown.  Additional information was provided as follows: The age at vaccination was not reported. The age group was captured as adult as per vaccine indication. Nurse reported that 17 patients received the first dose of Shingrix via subcutaneous route, which led to intramuscular formulation administered by other route. Some of them were female patients. Nurse did not provide initials, date of birth, lot number and expiration dates of the vaccines. She did not said how many patients were male and how many were female. This is 1 of the 17 cases, reported by same reporter.   Follow up information received from the nurse on 3rd April 2020: The patient's demographic details were updated. Concurrent medical conditions included gastroesophageal reflux disease (started on 17th October 2010), coronary artery calcification (started on 28th November 2017) and chronic cough (started on 28th November 2017).  On 16th January 2020, the patient received the 1st dose of Shingrix (subcutaneous). The batch number and expiry date details were updated. On 16th January 2020, less than a day after receiving Shingrix, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was recovered/resolved. The reporter considered the injection site pain to be unrelated to Shingrix. The VAERS details were updated.
Low-grade fever within 3 hours after vaccination leading to high fever (102+) after 48 hours.
Received vaccination for Adacel. Onset of pain was later that night and was 6/10 pain. The muscle pain at the injections site. The worse pain was after 1 week, then the pain tapered off, but the patient still has pain on an off. The most pain is when patient raises her arm overhead. She also experiences weakness in the arm on which the injection occurred.
10 minutes after injection a metallic bad taste in mouth. By 3:00pm...getting chills.... then started running low grade fever..by 11:00pm 101 temp. My injection site hurts and palm size red raised right below injection site is red hot. This continues thru 04/02/2021 with fever going down to 99 and back up to 101.5. Early morning 04/03/2021 my left arm is so tender can't sleep on left side.  By 2:00pm fever breaks..but back up to 100 by 7:00pm and overnight to 04/04/2021. Red raised bump and injection site still angry red and painful to touch. My normal body temp is 97.6 and I competed on stress fracture on right tibula so have high pain tolerance. This kicked me on my butt. 04/04/2021 temp at 99.0 Left arm tender and angry red.
My daughter has a huge red welt on her right arm at the injection site - size of grapefruit, it is extremely warm and sensitive. It hurts A LOT to touch and limits her arm movement.